Tower Research Capital LLC (TRC) - CHEMBIO DIAGNOSTICS INC ownership

CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 38 filers reported holding CHEMBIO DIAGNOSTICS INC in Q1 2022. The put-call ratio across all filers is 2.81 and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of CHEMBIO DIAGNOSTICS INC
ValueSharesWeighting
Q1 2023$4
+100.0%
9,810
-0.2%
0.00%
Q4 2022$2
-100.0%
9,834
-7.1%
0.00%
Q3 2022$4,000
-42.9%
10,591
-4.4%
0.00%
Q2 2022$7,000
+16.7%
11,073
+52.1%
0.00%
Q1 2022$6,000
+200.0%
7,282
+712.7%
0.00%
Q3 2021$2,0000.0%896
+32.3%
0.00%
Q2 2021$2,000
-85.7%
677
-83.0%
0.00%
Q1 2021$14,000
-48.1%
3,991
-29.5%
0.00%
-100.0%
Q4 2020$27,000
-70.3%
5,660
-69.8%
0.00%0.0%
Q3 2020$91,000
+1200.0%
18,746
+785.9%
0.00%
Q2 2020$7,000
+600.0%
2,116
+2016.0%
0.00%
Q1 2020$1,000
-87.5%
100
-94.4%
0.00%
-100.0%
Q4 2019$8,000
+300.0%
1,771
+523.6%
0.00%
Q3 2019$2,000
-66.7%
284
-76.3%
0.00%
Q1 2019$6,000
-71.4%
1,200
-67.8%
0.00%
-100.0%
Q4 2018$21,000
+2000.0%
3,721
+3621.0%
0.00%
Q1 2017$1,0001000.00%
Q4 2015$0
-100.0%
0
-100.0%
0.00%
Q2 2015$3,000551
+359.2%
0.00%
Q1 2015$0
-100.0%
120
-90.9%
0.00%
Q4 2014$5,0001,321
+1111.9%
0.00%
Q2 2014$0
-100.0%
109
-84.4%
0.00%
Q1 2014$2,000
-71.4%
700
-66.7%
0.00%
-100.0%
Q4 2013$7,000
+600.0%
2,102
+425.5%
0.00%
Q3 2013$1,000
-75.0%
400
-54.6%
0.00%
Q2 2013$4,0008810.00%
Other shareholders
CHEMBIO DIAGNOSTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Penbrook Management LLC 354,670$887,0000.55%
Newbridge Financial Services Group, Inc. 61,675$154,0000.10%
GAGNON SECURITIES LLC 47,793$119,0000.02%
Phocas Financial Corp. 30,000$75,0000.01%
ROYCE & ASSOCIATES LP 491,453$1,229,0000.01%
SEGALL BRYANT & HAMILL, LLC 701,318$1,754,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 179,680$449,0000.01%
Jump Financial, LLC 37,900$95,0000.01%
Cutler Group LLC / CA 44,918$112,0000.01%
Virtu Financial LLC 19,653$49,0000.00%
View complete list of CHEMBIO DIAGNOSTICS INC shareholders